Mark Robinson is a seasoned professional with extensive experience in the pharmaceutical industry, currently serving as a Senior Executive Therapeutic Specialist at Insmed Incorporated since January 2018. Robinson has been recognized multiple times as a President’s Club Winner from 2019 to 2024 and has contributed to a rare disease launch in the pulmonary-infectious disease sector. Previously, Robinson held positions at Intercept Pharmaceuticals and Boehringer Ingelheim, garnering awards for core values and top sales performance, including a Core Values Award and a Top 10% national TRx volume achievement. Robinson also achieved milestone goal attainments at Vertex Pharmaceuticals and completed management development programs at Boehringer Ingelheim, where a rating of Tier 1 was earned. Robinson holds a Bachelor of Science degree in Marine Biology from the University of North Carolina at Wilmington.
This person is not in the org chart
This person is not in any teams
This person is not in any offices